EPHA2, a promising therapeutic target for hepatocellular carcinoma

被引：7
|
作者：
Wang, Hao
Qiu, Wei [1 ]
机构：
[1] Loyola Univ Chicago, Stritch Sch Med, Dept Surg, Maywood, IL 60153 USA
来源：
MOLECULAR & CELLULAR ONCOLOGY | 2021年 / 8卷 / 03期
基金：
美国国家卫生研究院;
关键词：
EPHA2; HCC; AKT; STAT3; JAK1; INHIBITION; RECEPTOR; LIGAND;
D O I：
10.1080/23723556.2021.1910009
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Identifying critical drivers of oncogenesis and tumor progression is essential for developing effective hepatocellular carcinoma (HCC) therapeutics. Our recent findings has demonstrated that targeting Ephrin Receptor A2 (EPHA2) suppresses HCC initiation and progression by dual inhibition of the Protein Kinase B (AKT) and Signal Transducer and Activator of Transcription 3 (STAT3) signaling.
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Augmenter of Liver Regeneration Protein: A Promising Therapeutic Target for Hepatocellular Carcinoma
    Hora, Sandhya
    Mishra, Savita
    Mathur, Neha
    Aeri, Vidhu
    Katare, Deepshikha Pande
    ASIAN JOURNAL OF PHARMACEUTICS, 2018, 12 (02) : S740 - S746
  • [22] Oncogenic functions and therapeutic targeting of EphA2 in cancer
    Wilson, Kalin
    Shiuan, Eileen
    Brantley-Sieders, Dana M.
    ONCOGENE, 2021, 40 (14) : 2483 - 2495
  • [23] EphA2 in Cancer: Molecular Complexity and Therapeutic Opportunities
    Toracchio, Lisa
    Carrabotta, Marianna
    Mancarella, Caterina
    Morrione, Andrea
    Scotlandi, Katia
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (22)
  • [24] MicroRNA-26b Enhances the Radiosensitivity of Hepatocellular Carcinoma Cells by Targeting EphA2
    Jin, Qiao
    Li, Xiang Jun
    Cao, Pei Guo
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2016, 238 (02): : 143 - 151
  • [25] EFNA1 ligand and its receptor EphA2: potential biomarkers for hepatocellular carcinoma
    Cui, Xiang-Dan
    Lee, Mi-Jin
    Yu, Goung-Ran
    Kim, In-Hee
    Yu, Hee-Chul
    Song, Eun-Young
    Kim, Dae-Ghon
    INTERNATIONAL JOURNAL OF CANCER, 2010, 126 (04) : 940 - 949
  • [26] COE targets EphA2 to inhibit vasculogenic mimicry formation induced by hypoxia in hepatocellular carcinoma
    Chen, Jue
    Dai, Shu-Ying
    Wu, Su
    Wu, Meng-Ke
    Yu, Ke-Ke
    Liu, Jun-Chi
    Chang, Jia-Yu
    Liu, Yan-Qing
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [27] Increased expression of EphA2 and E-N cadherin switch in primary hepatocellular carcinoma
    Fan, Min
    Liu, Yu
    Xia, Fada
    Wang, Zhuolu
    Huang, Yun
    Li, Jingdong
    Wang, Zhiming
    Li, Xinying
    TUMORI JOURNAL, 2013, 99 (06): : 689 - 696
  • [28] miR-26b enhances radiosensitivity of hepatocellular carcinoma cells by targeting EphA2
    Jin, Qiao
    Li, Xiang Jun
    Cao, Pei Guo
    IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2016, 19 (08) : 851 - 857
  • [29] Dual targeting of EphA2 and FAK in ovarian carcinoma
    Shahzad, Mian M. K.
    Lu, Chunhua
    Lee, Jeong-Won
    Stone, Rebecca L.
    Mitra, Rahul
    Mangala, Lingegowda S.
    Lu, Yiling
    Baggerly, Keith A.
    Danes, Christopher G.
    Nick, Alpa M.
    Halder, Jyotsnabaran
    Kim, Hye-Sun
    Vivas-Mejia, Pablo
    Landen, Charles N.
    Lopez-Berestein, Gabriel
    Coleman, Robert L.
    Sood, Anil K.
    CANCER BIOLOGY & THERAPY, 2009, 8 (11) : 1027 - 1034
  • [30] Expression of the EphA2 Gene in Esophageal Carcinoma Tissues
    Baolan Hao Shanshan Li Hongyan Zhang Aihua Yan Xiuhua Ren Department of Pathology
    Department of Pathology
    Chinese Journal of Clinical Oncology, 2006, (02) : 92 - 95
12345